This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia.
A solid body of published and preliminary evidence leveraging systematic phenotypic and whole cell genome analysis and innovative surveillance technology has provided great insight into the epidemiology of perioperative bacterial transmission and healthcare-associated infection (HAI) development. This work has led us to three primary assertions that serve as the foundation of our scientific premise: 1) Further progress towards HAI prevention is needed, 2) Prevention of perioperative ESKAPE transmission is an important improvement target, and 3) An evidence-based, multi-faceted program can reduce perioperative ESKAPE transmission. Further work to generate intraoperative hand hygiene improvement is indicated. We hypothesize that the proposed program will generate sustained reductions in OR ESKAPE exposure and S. aureus transmission that will lead to sustained reductions in perioperative HAIs.
Study Type
OBSERVATIONAL
Enrollment
39
This is an alcohol dispenser that will be worn on the Anesthesia Providers scrub pants, near the hip. It will be worn by both the attending physician and the resident physician/CRNA/SRNA. The device is produced by Georgia-Pacific.
University of Iowa
Iowa City, Iowa, United States
ESKAPE transmission events with and without the body worn device
Reduce the number of Enterococcus, Staphylococcus aureus, Pseudomonas, and other gram-negative (i.e., Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) transmission events
Time frame: Up to 96 hours from the surgial procedure
The epidemiology of ESKAPE transmission events
To characterize the epidemiology of ESKAPE transmission with and without the device according to incidence.
Time frame: Up to 90 days from surgery
The epidemiology of ESKAPE transmission events
To characterize the epidemiology of ESKAPE transmission with and without the device according to reservoir of origin.
Time frame: Up to 90 days from surgery
The epidemiology of ESKAPE transmission events
To characterize the epidemiology of ESKAPE transmission with and without the device according to transmission location(s).
Time frame: Up to 90 days from surgery
The epidemiology of ESKAPE transmission events
To characterize the epidemiology of ESKAPE transmission with and without the device according to portal of entry (stopcock).
Time frame: Up to 90 days from surgery
The epidemiology of ESKAPE transmission events
To characterize the epidemiology of ESKAPE transmission with and without the device according to mode (within or between-case).
Time frame: Up to 90 days from surgery
90-Day Healthcare-Associated Infections
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Number of infections occurring within 90 days of surgery
Time frame: 90 days following surgery